#4-39E. Navigating Reproductive Health in Systemic Lupus Erythematosus (Nat Rev Rheumatol, 2026)

Are you struggling to optimize pregnancy management and medication strategies for your patients with systemic lupus erythematosus (SLE)? Today's episode dives into a comprehensive review that covers the fertility of SLE patients, the underlying mechanisms of pregnancy complications, and the latest clinical guidelines for management during the perinatal and lactation periods. The most critical takeaway from this research emphasizes that maintaining disease remission for at least 6 to 12 months prior to conception using pregnancy-compatible medications is absolutely crucial for reducing the risk of severe maternal and fetal complications. However, when critically appraising this paper, it is important to note that much of the current evidence on medication safety and complication pathways heavily relies on small-scale retrospective observational studies, highlighting a significant need for larger, prospective clinical trials. For clinicians, these insights are highly relevant as they directly translate into formulating safe, multidisciplinary care plans and shared decision-making, allowing you to optimize daily practice and significantly improve reproductive outcomes for your SLE patients.

Citation: Bultink, I. E. M., Dankers, W., de Boer, M. A., & Schreiber, K. Fertility, pregnancy and lactation in women with systemic lupus erythematosus. Nature Reviews Rheumatology. 2026. DOI: https://doi.org/10.1038/s41584-026-01366-6

Disclaimer: This audio summary is based on personal interpretation and does not guarantee the exact content of the original paper. Please refer to the original article for details.